Health Care: Drugs

Rigel Pharmaceuticals Inc (RIGL: NASDAQ)

$3.67 0.1 | 2.8%
09/30/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 28.89M 8.25M 7.15M 2.25M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 28.89M 8.25M 7.15M 2.25M
Selling, General, and Administrative Expenses 17.81M 22.50M 19.61M 22.85M
Research & Development 62.83M 67.70M 75.33M 78.78M
Operating Income before D & A (EBITDA) -51.74M -81.95M -87.79M -99.38M
Depreciation & Amortization 1.44M 2.36M 2.59M 2.43M
Interest Income 222.00K 243.00K 442.00K 537.00K
Other Income - Net 57.00K -9.20M 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -52.90M -93.27M -91.62M -101.27M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -52.90M -93.27M -91.62M -101.27M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -51.46M -90.91M -89.03M -98.84M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -51.46M -90.91M -89.03M -98.84M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -51.46M -90.91M -89.03M -98.84M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-51.46M -90.91M -87.35M -98.84M
Preferred Dividends
Net Income Available To Common -51.46M -90.91M -89.03M -98.84M
Basic EPS from Continuing Ops. -0.58 -1.04 -1.02 -1.32
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.58 -1.04 -1.02 -1.32
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.58 -1.04 -1.02 -1.32
Basic Normalized Net Income/Share -0.58 -1.04 -1.00 -1.32
EPS fr Continuing Ops. -0.58 -1.04 -1.02 -1.32
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.58 -1.04 -1.02 -1.32
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.58 -1.04 -1.02 -1.32
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.58 -1.04 -1.00 -1.32
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with RIGL

Latest RIGL Headlines from TheStreet

More Financial News for RIGL

Press Releases for RIGL

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter